2. Amyotrophic lateral sclerosis Clinical trials / Disease details


Clinical trials : 624 Drugs : 611 - (DrugBank : 160) / Drug target genes : 172 - Drug target pathways : 225

  
1 trial found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT04950933
(ClinicalTrials.gov)
June 1, 202027/6/2021The Treatment of Amyotrophic Lateral Sclerosis With Huollingshengji GranulesA Multi-center, Randomized, Double-blind, Positives Parallel Controlled, Phase ? Clinical Trial to Evaluate the Efficacy and Safety of Huollingshengji Granules in the Treatment of Amyotrophic Lateral Sclerosis (Spleen qi Deficiency, Kidney Yang Deficiency Syndrome)Amyotrophic Lateral SclerosisDrug: Huolingshengji Granules;Drug: Riluzole tabletPeking University Third HospitalThe Second Hospital of Hebei Medical UniversityRecruiting45 Years70 YearsAll144Phase 2/Phase 3China